SCHEMBL9401504

SCHEMBL9401504

COC(=O)C1=C(C)NC(C)=C(C(=O)O)C1c1ccsc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1B Q00975 1/20 0.64
HSD17B10 Q99714 7/20 0.63
TSHR P16473 4/20 0.63
KDM4E B2RXH2 8/20 0.60
CASP1 P29466 3/20 0.60
PKM P14618 1/20 0.60
HPGD P15428 4/20 0.58
ADORA3 P0DMS8 1/20 0.53
POLB P06746 3/20 0.52
CASP7 P55210 2/20 0.52
USP2 O75604 1/20 0.52
ALDH1A1 P00352 4/20 0.51
HTT P42858 2/20 0.51
GLA P06280 1/20 0.51
GAA P10253 1/20 0.51
RAB9A P51151 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CACNA1F O60840 1/20 0.49
CACNA1D Q01668 1/20 0.49
CACNA1S Q13698 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3033425 0.94 HSD17B10 (0.69) CACNA1BHSD17B10TSHRKDM4ECASP1
SCHEMBL11004996 0.88 PKM (0.61) CACNA1BHSD17B10TSHRKDM4ECASP1
SCHEMBL6951320 0.81 ADORA3 (0.76) CACNA1BHSD17B10TSHRKDM4EHPGD
SCHEMBL27388698 0.81 CACNA1B (0.60) CACNA1BHSD17B10TSHRKDM4ECASP1
SCHEMBL3002791 0.81 ADORA2B (0.67) CACNA1BHSD17B10TSHRKDM4ECASP1
SCHEMBL7265410 0.80 TSHR (0.65) CACNA1BHSD17B10TSHRKDM4EHPGD
SCHEMBL7158395 0.79 ADORA3 (0.60) CACNA1BHSD17B10TSHRKDM4EHPGD
SCHEMBL9272854 0.78 CACNA1F (0.69) CACNA1BHSD17B10TSHRKDM4EHPGD
SCHEMBL9401767 0.78 KDM4E (0.68) HSD17B10TSHRKDM4EHPGDADORA3
SCHEMBL27387459 0.78 CACNA1B (0.56) CACNA1BHSD17B10KDM4ECASP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5286869-A Vasodilators and anticoagulants FUJIREBIO KABUSHIKI KAISHA (JP) 1994-02-15 US disclosed
EP-0403957-A2 Optical active 1,4-dihydropyridine derivates FUJIREBIO INC. (JP) 1990-12-27 EP disclosed